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ABSTRACT
Introduction Despite higher incidence of brain injury 
among Aboriginal compared with non- Aboriginal 
Australians, suboptimal engagement exists between 
rehabilitation services and Aboriginal brain injury survivors. 
Aboriginal patients often feel culturally insecure in hospital 
and navigation of services post discharge is complex. 
Health professionals report feeling ill- equipped working 
with Aboriginal patients. This study will test the impact of a 
research- informed culturally secure intervention model for 
Aboriginal people with brain injury.
Methods and analysis Design: Stepped wedge cluster 
randomised control trial design; intervention sequentially 
introduced at four pairs of healthcare sites across Western 
Australia at 26- week intervals.
Recruitment: Aboriginal participants aged ≥18 years within 
4 weeks of an acute stroke or traumatic brain injury.
Intervention: (1) Cultural security training for hospital 
staff and (2) local, trial- specific, Aboriginal Brain Injury 
Coordinators supporting participants.
Primary outcome: Quality- of- life using EuroQOL- 5D- 3L 
(European Quality of Life scale, five dimensions, three 
severity levels) Visual Analogue Scale score at 26 weeks 
post injury. Recruitment of 312 participants is estimated 
to detect a difference of 15 points with 80% power at the 
5% significance level. A linear mixed model will be used to 
assess the between- condition difference.
Secondary outcome measures: Modified Rankin Scale, 
Functional Independence Measure, Modified Caregiver 
Strain Index, Hospital Anxiety and Depression Scale at 
12 and 26 weeks post injury, rehabilitation occasions 
of service received, hospital compliance with minimum 
care processes by 26 weeks post injury, acceptability of 
Intervention Package, feasibility of Aboriginal Brain Injury 
Coordinator role.
Evaluations: An economic evaluation will determine the 
potential cost- effectiveness of the intervention. Process 
evaluation will document fidelity to study processes 
and capture changing contexts including barriers to 
intervention implementation and acceptability/feasibility of 
the intervention through participant questionnaires at 12 
and 26 weeks.
Ethics and dissemination The study has approvals from 
Aboriginal, university and health services human research 
ethics committees. Findings will be disseminated through 
stakeholder reports, participant workshops, peer- reviewed 
journal articles and conference papers.
Trial registration number ACTRN12618000139279.
INTRODUCTION
Background and rationale
The Aboriginal and Torres Strait Islander 
population (hereafter respectfully referred 
to as Aboriginal), Australia’s First Nations 
Strengths and limitations of this study
 ► This is the first stepped- wedge randomised con-
trol trial to explore the effects of an intervention on 
access to rehabilitation services and outcomes for 
Aboriginal survivors of brain injury.
 ► The study involves strong collaboration between 
Aboriginal and non- Aboriginal researchers and 
health service providers to maximise the opportunity 
for translation into policy and practice.
 ► We will gather the first comprehensive data on re-
source utilisation, costs and outcomes for an eco-
nomic evaluation of care facilitation roles applicable 
to the study cohort.
 ► Ongoing service developments external to the study 
may influence the outcomes of participants; while 
these contextual factors will be monitored and re-
ported as part of the study’s process evaluation, 
their effects are beyond the control of the study.
 ► By the nature of the stepped- wedge design, with 
hospital and region- wide interventions difficult to 
conceal, blinding to intervention may not always be 
possible.
2 Armstrong E, et al. BMJ Open 2021;11:e045898. doi:10.1136/bmjopen-2020-045898
Open access 
peoples, constitutes 3.3% of the Australian population1 
and consists of many different cultural groups, with more 
than 120 separate Aboriginal languages spoken (240 at 
the time of colonisation).2 Aboriginal Australians are 
overall younger than other Australians (median age 23 
vs 38 years),1 with health inequities well- documented.3 
The incidence of brain injury is significantly greater 
in Aboriginal than non- Aboriginal Australians, with 
stroke and traumatic brain injury (TBI) occurring up 
to three times more frequently4–8 and functional depen-
dence at hospital discharge three times more likely.4 
Motor, communication, sensory and cognitive deficits 
all adversely affect long- term quality of life, including 
employment status and prospects, family relationships, 
social participation and mental health.9–12 Ongoing 
engagement between Aboriginal brain injury survivors 
and mainstream hospital- based rehabilitation services is 
limited, with complex service pathways to navigate post 
discharge.13 14 This results in confusion, communication 
breakdown and lack of support for brain injury survi-
vors, their families and communities. Poor service leads 
to ongoing challenges and re- hospitalisations that incur 
additional health system costs.15 16
Despite some recent improvements in access to acute 
services such as stroke units and thrombolysis,17 multiple 
issues persist among those requiring subsequent care: 
lack of practical, understandable information regarding 
brain injury; limited availability of Aboriginal Liaison 
Officers to assist with navigating services; lack of inter-
preter services; racist attitudes/assumptions of some 
healthcare providers; and underservicing of rural and 
remote areas.11 18–21 Many health professionals feel under-
prepared to work with Aboriginal patients in a culturally 
secure manner21–23 and few people consult Aboriginal 
Health Services specifically for brain injury- related 
concerns.18
The current trial will test the impact of a research- 
informed culturally secure21 intervention model for 
Aboriginal people with brain injury in Western Australia 
(WA) (see figure 1). Cultural security refers to ensuring 
that Aboriginal cultural values, world views and ways of 
working are incorporated at each stage of care for an 
Aboriginal person and that services will not compromise 
the legitimate cultural rights, values and expectations of 
Aboriginal people.21 The trial addresses the systemic chal-
lenges identified in our research, using existing resources 
where possible and developing a site and service- specific 
sustainable evidence- based approach. Due to the chronic 
consequences of brain injury, the proposed intervention 
package follows a Chronic Care Model (CCM),24 demon-
strated to be successful in the management of other 
chronic conditions. The CCM has been modified for the 
purpose of this trial to incorporate specific components 
related to brain injury. The study will occur in partner-
ship with state government- funded health services and 
Aboriginal Community Controlled Health Services, as 
well as national policymakers.
A stepped- wedge cluster design was chosen given: (1) 
the population under focus is under- represented in reha-
bilitation services, is vulnerable in terms of comorbidities 
and has poorer overall health outcomes. Withholding an 
additional service intervention likely to do more good 
than harm at particular sites within a trial would pose an 
ethical dilemma; (2) the design still includes a control 
condition, making comparisons of intervention effective-
ness possible; (3) the sequential introduction of the inter-
vention to clusters facilitates the assessment of changes in 
service standards through secular trends over time; (4) 
a concurrent roll- out of the intervention across a large 
geographical area (975 685 square miles), encompassing 
rural and remote areas, was not feasible.
Aboriginal research framework
The trial will employ principles aligned with an Aborig-
inal Research Framework as recommended for health 
contexts25 and incorporates central notions from Indige-
nous Standpoint Theory26 27 which relate to research with 
Indigenous peoples, namely: inclusion and leadership 
by Aboriginal researchers; acceptance of colonisation as 
a social determinant of health/disability; acknowledge-
ment of the diversity of Aboriginal communities; use 
of local languages; and Aboriginal community capacity 
building.
Objectives
The aims of this trial are to: (1) improve delivery of reha-
bilitation services to Aboriginal people post brain injury 
(stroke and traumatic brain injury), (2) improve overall 
health outcomes of this group, (3) conduct an economic 
evaluation to support the business case for resourcing 
future rehabilitation services if the intervention is deter-
mined to be cost- effective and (4) explore the accept-
ability of the intervention from the perspectives of health 
professionals and Aboriginal participants involved, and to 
use this information to assist in interpretation and trans-
lation of findings.
Figure 1 (Colour online) A map of the state of Western 
Australia, with major regions highlighted, in relation to the 
whole of Australia. (Image of state regions reproduced with 
the permission of the Western Australian Country Health 
Service.)
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Our primary hypothesis is that compared with usual 
care (UC), implementation of the proposed intervention 
package (IP) will result in at least a 15- point higher score 
on the EuroQOL-5D- 3L28 (European Quality of Life scale, 
comprised of five dimensions: Mobility, Self- care, Usual 
activity, Pain and discomfort, Anxiety and depression; and 
3 severity levels) Visual Analogue Scale (VAS) at 26 weeks 
post injury. Our secondary hypotheses are:
1. Compared with UC, implementation of the IP will re-
sult in improvement in service delivery at 12 and 26 
weeks post injury as measured by increased occasions 
of service.
2. Compared with UC, implementation of the IP will re-
sult in improvement in service delivery at 12 and 26 
weeks post injury as measured by indicators of essential 
processes of care.
3. Compared with UC, implementation of the IP will re-
sult in reduction in disability (modified Rankin Scale 
(mRS))29 and greater independence (Functional Inde-
pendence Measure (FIM))30 at 12 and 26 weeks post 
injury.
4. Compared with UC, implementation of the IP will re-
sult in less carer burden (Modified Caregiver Strain 
Index)31 and less brain injury survivor anxiety and de-
pression (Hospital Anxiety and Depression Scale)32 at 
12 and 26 weeks post injury.
5. The culturally sensitive IP will be cost- effective (benefits 
gained will justify costs for delivering the intervention; or lead 
to cost- offsets from less severe disease) when compared with 
UC 26 weeks post injury.
6. The IP will be acceptable to health professionals and 
Aboriginal participants and their families, and the 
Aboriginal Brain Injury Coordinator role is feasible.
METHODS
The reporting of the methods aligns with the Standard 
Protocol Items: Recommendations for Interventional 
Trials guidelines33 for clinical trial protocols and incor-
porates relevant details from the Consolidated Standards 
of Reporting Trials extension statement on the reporting 
of stepped- wedge cluster randomised control trials 
(CRCTs).34
Trial design
As noted above, a stepped- wedge CRCT design35 will be 
used, with paired healthcare sites functioning as clusters 
(see figure 2). The pairing was done to prevent contam-
ination between sites since it is common for patients 
to be transferred between the rural and metropolitan 
sites that are paired together. The pairing also enables 
adjustment for differences in numbers of participants 
recruited in the rural/metropolitan site pairs. Twen-
ty- six weeks of baseline control data will be obtained 
prior to implementation of the intervention, which will 
be introduced sequentially to all sites at 26- week inter-
vals. Control data will continue to be collected at each 
site until the intervention commences. The intervention 
will continue until all sites have received the interven-
tion for at least 52 weeks. The sequence of receipt of 
intervention will be determined by randomisation of 
clusters.
This research is a complex intervention due to the 
multiple components involved, the varied sites that incor-
porate diverging local contexts, potential contamina-
tion across sites due to movement of some participants 
between rural and metropolitan hospitals within the study 
period and potential clinical service changes during the 
intervention period. A process evaluation36 will be under-
taken alongside the measurement and analysis of the 
intervention and primary outcomes as per the Template 
for Intervention, Description and Replication (TIDieR) 
checklist.37
A Steering Committee will oversee the study, consisting 
of the chief investigators (CIs), assisted by the trial 
manager. The Data Collection and Management Team 
consists of six CIs, assisted by the trial data and opera-
tions manager. Working parties for both intervention 
conditions will consist of CIs and associate investigators 
experienced in cultural security training and Aborig-
inal workforce organisation. A Design Working Party, 
consisting of the principal investigator and six other CIs, 
will oversee any protocol amendments.
Participants
Aboriginal people aged ≥18 years who have suffered 
an acute stroke or TBI will be recruited within 4 weeks 
post injury. Specific inclusion and exclusion criteria are 
presented in figure 3 along with relevant definitions.38–41
Participating sites will include eight acute hospital sites 
across WA (four metropolitan and four regional). The 
sites were chosen as the metropolitan hospitals constitute 
the three major tertiary hospitals in WA and a secondary 
hospital with an acute stroke unit. The regional hospi-
tals constitute four large regional centres. All sites were 
known to have significant numbers of Aboriginal people 
admitted. Transfer across hospitals within WA is antici-
pated, and ‘step- down’, that is, non- acute rehabilitation 
sites will be involved (ethics approval obtained) for partic-
ipant follow- up but not recruitment.
Figure 2 Stepped- wedge design.
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Interventions
The intervention periods will vary across sites (between 1 
and 2.5 years) depending on cluster randomisation under 
the stepped- wedge design. The intervention will consist 
of two components—(1) cultural security training (CST) 
for hospital staff, and (2) introduction of an Aboriginal 
Brain Injury Coordinator (ABIC) at each site employed 
for 1 day/week.
Cultural security training of hospital staff
Twenty health professionals at each site (nursing, medical 
and allied health) will complete the initial CST of 3 hours 
face- to- face followed by 3 hours online, focusing on chal-
lenges surrounding brain injury. The face- to- face sessions 
will be co- facilitated by a local Aboriginal cultural security 
trainer and a member of the research team. The online 
component must be completed within 3–4 weeks of 
completion of the face- to- face component. The training 
will be offered at each site every 6 months to address staff 
attrition. The materials and format of the training are 
based on extensive consultation with Aboriginal people 
after brain injury and their families,11 12 20 21 42 Aboriginal 
and non- Aboriginal health professionals and Aboriginal 
experts in cultural security, including the second author. 
They are based on principles of cultural security,21 an 
Aboriginal model of health43 and ‘clinical yarning’.42 
Videos of Aboriginal people who have experienced brain 
injury discussing their hospital experiences are central, 
with reflective exercises and case studies embedded.
Aboriginal Brain Injury Coordinator
An Aboriginal person with a relevant health or commu-
nity care background will be employed 1 day/week at 
each of the trial sites as an ABIC. The role is based on 
the Neurological Nurse and Neurocare model of the 
Neurological Council of Western Australia (NCWA)44—a 
community neurological nursing service. The ABIC will 
see participants in hospital and up until 26 weeks post 
injury onset, providing education, support, liaison and 
advocacy services to participants and their families. The 
ABIC will receive 12 hours of training and ongoing 
support from the partner clinical team (NCWA) and the 
research team. ABICs will be located in the hospital, the 
local Aboriginal Community Controlled Health Service, 
or offices of NCWA, depending on site preference. 
Follow- up of participants will occur through face- to- face, 
phone or telehealth contact as agreed.
An intervention protocol provided only to the ABICs 
outlines prescribed activities that must be performed 
within specific time frames.
Intervention integrity
Adherence to content and staff attendance at the face- 
to- face component of the CST will be recorded by the 
researcher involved in the site- training. Completion of 
the online training component will be recorded on the 
secure website containing the online materials. REDCap 
(Research Electronic Data Capture) data entry related to 
the ABIC role will be monitored on a monthly basis. Feed-
back will be provided to the ABIC if data is missing or 
prescribed activities outlined in the intervention protocol 
have not been performed.
Outcomes
Primary outcome
The primary outcome measure is the EuroQOL-5D- 3L 
VAS score administered at 26 weeks post injury. The 
EQ- 5D28 has previously been used with stroke and TBI 
survivors,45 46 validated in different countries and cultural 
settings, and can be administered by face- to- face or tele-
phone interview, or as a self or proxy mail- out. The VAS 
involves a 100- point vertical scale measuring quality of life 
on the day of administration as perceived by participants. 
The scale endpoints are labelled ‘Best imaginable health 
state’ and ‘Worst imaginable health state.’
Secondary outcome measures
These relate to the health outcomes of post- stroke symp-
toms and functional status (mRS),29 functional indepen-
dence (FIM),30 burden of care (Modified Caregiver Strain 
Index),31 anxiety and depression (Hospital Anxiety and 
Depression Scale)32 and clinical service provision (allied 
health rehabilitation sessions and minimum process of 
care indicators). Figure 4 outlines the minimum processes 
of care indicators developed for this study, based on clin-
ical guidelines47 and best practice statements.48 Partici-
pant (Aboriginal people post stroke/TBI) satisfaction, 
reflecting acceptability of hospital services and the ABIC 
services will be assessed through questionnaires adminis-
tered either face- to- face or by phone/telehealth facility 
and incorporated into the process evaluation. Staff 
Figure 3 Inclusion and exclusion criteria. TIA, transient 
ischaemic attack; ICD- 10, International Classification of 
Diseases, Tenth Revision; NIHSS, National Institutes of Health 
Stroke Scale.
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satisfaction with the CST will be assessed through ques-
tionnaires administered both face- to- face and online. 
Feasibility of the ABIC role will be assessed through the 
process evaluation service data collection.




Baseline assessments will be undertaken by qualified 
assessors with an Aboriginal Liaison Officer present 
where possible. Demographic information (age, gender, 
language group, place of residence) will be collected at 
baseline assessment. Follow- up assessments will be under-
taken by an independent qualified blinded assessor at 
weeks 12 and 26 post injury. All assessments will take 
place at participants’ place of residence, in the hospital or 
Aboriginal Community Controlled Health Service clinic 
as convenient for the participant, or by phone/telehealth 
as appropriate. Any deviation from the prescribed proto-
cols will be recorded as a protocol deviation.
Service data
Occasions of allied health rehabilitation service across the 
26 weeks post injury will be collected through a medical 
file review process and through access to hospital admin-
istrative data systems. Minimum process of care indica-
tors will capture data on whether identified key processes 
occurred across the first 26 weeks post injury. The data 
collection will be undertaken by an independent blinded 
auditor.
The activities of the ABIC involving direct and indirect 
contact with participants will be recorded in the elec-
tronic case report form.
Process evaluation data
Data will be collected to enable evaluation of poten-
tial causal and overall contextual factors related to the 
outcomes of the study, as recommended by Medical 
Research Council (MRC)49 and as included in the 
TIDieR checklist.37 Ongoing site- specific descriptive 
information will be collected related to the hospital 
context, for example, general staffing levels, staff turn-
over, policy changes. Factors related to the impact of 
the CST including staff satisfaction with, and perceived 
usefulness of training will be measured through evalu-
ation questionnaires. A questionnaire on participants’ 
hospital experiences and brain injury- related services 
received will be administered by blinded assessors at 12 
and 26 weeks. A questionnaire addressing participation 
satisfaction with the ABIC services will also be adminis-
tered. A detailed outline of the process evaluation will be 
published separately.36
Resource utilisation
Resource utilisation information will be collected using 
programme administrative data, hospital data captured 
from medical records and self- report using a standardised 
questionnaire. General service data will be collected for 
all patients at the week 12 and 26 visits regarding inpa-
tient and outpatient rehabilitation- related sessions (reha-
bilitation specialist, allied health sessions). Unit prices 
for participant self- reported resource use items will be 
obtained from published sources or be derived directly 
from the trial in terms of programme delivery costs and 
hospital care.
A summary of the data collection schedule is provided 
in figure 5.
Sample size
To estimate the required sample size we calculated an 
effect size of d=0.6, based on an anticipated improve-
ment of 15 points on the EuroQOL-5D VAS, with an SD 
of 25.46 GPower V.3.150 estimated that a total of 90 partic-
ipants required to detect this difference with 80% power 
and α=0.05. After adjusting for the design effect51 for a 
four- step stepped- wedge design with intra- class correla-
tion co- efficient (ICC)=0.08, one baseline step and one 
follow- up step, we estimated the total sample size required 
as 312.
Figure 4 Minimum processes of care.
Figure 5 Schedule of assessments. NIHSS, National 
Institutes of Health Stroke Scale; GCS, Glasgow Coma Scale; 
FIM, Functional Independence Measure; mRS, modified 
Rankin Scale; EuroQol- 5D- 3L, European Quality of Life scale, 
comprised of five dimensions and three severity levels; SAEs, 
serious adverse events.
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Participant completion and discontinuation
Participants have completed the study when the final 
follow- up visit is complete (week 26) and all data pertaining 
to this visit have been submitted to the study sponsor. 
Participants’ data will be withdrawn from the study if they 
withdraw consent, or if it is determined that trial involve-
ment poses a health or safety risk to the participant. Data 
collected up until the time of withdrawal will be used. 
Withdrawn participants will not be replaced. Retention 
of participants will be maximised by a letter/email/tele-
phone call in advance of the follow- up assessment date to 
remind participants of their enrolment in the study and 
facilitate organisation of follow- up assessments.
RANDOMISATION
Sequence generation
Clusters will be randomised at the beginning of the 
trial to determine the sequencing of the introduction 
of the intervention. Numbers of participants recruited 
in metropolitan sites are anticipated to be higher than 
in regional sites due to potential transfer of patients 
to tertiary metropolitan hospitals for early treatment 
post stroke/TBI. To minimise potential differences in 
participant numbers across steps, one metropolitan 
and one regional site will be paired prior to randomis-
ation, then these pairs of sites will be randomised. The 
pairings were primarily determined by existing stroke 
pathways between rural and metropolitan regions. 
Intervention commencement time will be assigned 
through use of a computer- generated sequence of 
random numbers. The process will allocate sites to 
one of four commencement periods (figure 2).
Implementation
The trial statistician will undertake the randomisation 
process and will be unaware of the identity/location of 
the sites involved.
All Aboriginal stroke and patients with TBI ≥18 
years of age admitted to hospital will be screened 
for study inclusion as per eligibility criteria. Those 
meeting criteria will be approached to participate by 
the hospital investigator, preferably with the assistance 
of a hospital- based Aboriginal Liaison Officer. If the 
person agrees to provision of their name to the trial 
team, a team member will discuss the trial further with 
the person and obtain informed consent, involving 
an interpreter as needed. ‘Aphasia friendly’ infor-
mation will be used to accommodate patients with 
communication disorders, cognitive issues and/or 
limited literacy. For patients with very severe impair-
ment, we will seek assent from the patient as well as 
proxy consent for research involvement from a person 
responsible (family member, friend, long- term carer 
or guardian) for the participant. Consent to partici-
pate in the CST will be obtained from all hospital staff 
completing the training. The same process will occur 
regardless of control/intervention phase of the trial.
Blinding
All assessors will be independent of the researchers 
involved in the intervention or trial. However, assessors in 
rural areas may be aware of whether their local hospital 
is in intervention or control phase. Therefore, it is not 
possible to blind all the assessors, patients or most investi-
gators with respect to whether the patients received inter-
vention or not. Follow- up assessors will be blinded to the 
baseline assessment of any given participant.
Data management
Electronic case report form
An electronic case report form (eCRF) will be completed 
for each participant summarising all clinical screening 
and study data. Participants will only be recorded by 
their participant number and initials in order to retain 
participant confidentiality. Data will be collected and 
managed using REDCap electronic data capturing tool. 
The trial manager and trial data and operations manager 
will monitor site compliance with study procedures and 
completion of the eCRFs. Site visits conducted inde-
pendently of the investigator team will include review of 
medical records, comparison with source documents and 
observation and discussion of the conduct of the study 
with the site contact.
Statistical methods
Unadjusted analyses
Descriptive statistics (consisting of the mean and SD 
or median and IQR or frequency and per cent) will be 
reported for all available data on the outcome measures 
at baseline, 12 weeks and 26 weeks. Precise details on the 
tables and descriptive statistics to be presented will be 
published separately in a statistical analysis plan (SAP), 
which will be finalised before the database is locked.
Adjusted analyses
The primary analysis will be on an intention- to- treat basis 
with each participant allocated to the site/treatment that 
he/she was originally recruited. If the amount of missing 
data at the primary endpoint exceeds 10%, multiple 
imputation will be performed under the assumption that 
data is missing at random. A sensitivity analysis consid-
ering assumptions about data missing not at random 
will be conducted. Additional details on the missing data 
imputation will be provided in the SAP.
Primary outcome analysis
A mixed effects linear regression model will assess the 
between- condition difference on EuroQOL-5D- 3L VAS 
score at 26 weeks post injury.
Secondary outcomes analyses
A mixed- effect regression model will be used to assess 
between- condition differences for each of the outcomes: 
occasions of service (1), functional independence 
(3), Modified Carer Strain Index and Hospital Anxiety 
and Depression Scale (4), at 12 and 26 weeks post 
injury. Minimum process of care indicators (2) will be 
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dichotomised (achieved/not achieved). Similarly, mRS 
will be dichotomised as good outcome (mRS 0–2) and 
poor outcome (mRS 3–6). A mixed- effect logistic regres-
sion model will assess between- condition differences on 
each of these binary variables at 12- and 26 weeks post- 
injury. Additional details about these models will be 
provided in the SAP; these will include plans for alter-
native models in case any of the proposed models fail to 
converge. Descriptive statistics for participant satisfaction, 
reflecting acceptability of hospital services, staff satisfac-
tion with the CST and feasibility of the ABIC role will be 
presented in terms of frequencies and percentages, but 
these outcomes will not be subject to any statistical model-
ling. A more in- depth analysis of these variables will be 
conducted qualitatively as part of our process evaluation, 
which is outlined in a separate paper.
Interim analysis
No interim analysis of efficacy is planned for the trial. 
However, if the Data Safety Monitoring Committee 
(DSMC—see below) members develop a safety concern 
following review of trial data (eg, an imbalance of serious 
adverse events (SAEs) between conditions), the DSMC 
may request an interim safety or efficacy analysis of the 
data.
Only the trial manager, trial data manager, trial stat-
istician and an independent statistician will have access 
to the final locked database. Investigators will view the 
results of the final analyses, but will not have access to 
raw data.
Economic analysis
Cost description analyses of each comparator condi-
tion will be detailed using a decision- analytical model. 
Intervention delivery costs will be included for the inter-
vention condition. The incremental (net) costs and 
benefits of the intervention (ie, quality- adjusted life years 
(QALYs) gained derived from EQ- 5D results) compared 
with control will be determined. Sensitivity and probabi-
listic multivariable uncertainty analyses will be performed 
to assess the robustness of results. The intervention 
will be judged cost- effective if the incremental cost per 
QALY gained is <AUD$50 000 (ie, the willingness- to- pay 
threshold). Cost- effectiveness acceptability curves will 
also be generated as a function of describing poten-
tial willingness- to- pay. This method provides a measure 
of magnitude and uncertainty of cost- effectiveness, 
expressed as a probability statement meaningful to policy-
makers. The statistical analysis plan and reporting of the 
economic evaluation will be guided by the Consolidated 
Health Economic Evaluation Reporting Standards state-
ment52 and the recommendations from the European 
Stroke Organisation Health Economic Working Group.53
Harm
An independent DSMC will regularly review the study 
data and make recommendations to the trial team. 
The Committee will consist of three members (at least 
one Aboriginal member) who are independent of the 
trial, have different disciplinary backgrounds and who 
have experience in the management of patients and the 
conduct of clinical trials. Ongoing review of trial safety 
data will be held at agreed intervals as determined by 
the DSMC members. Discussion about the final data will 
occur with the trial team at trial completion. The Steering 
Committee will make the final decision on whether to 
stop the trial due to safety concerns or ascertainment of 
undue risks to participants.
Safety assessments
Adverse events (AEs) that are possibly, probably or defi-
nitely attributable to the intervention will be reported 
via the eCRF. The investigator and designated study 
personnel will monitor each participant for AEs during 
the study. AEs that meet the criteria for serious, are consid-
ered SAEs and will be reported throughout the trial.
Patient and public involvement
Healing Right Way is informed by previous studies11 18–20 54 
that have prioritised the voices of Aboriginal people with 
brain injury and their families, as well as those of Aborig-
inal and non- Aboriginal health service providers. Healing 
Right Way involves collaboration between a team of 
Aboriginal and non- Aboriginal researchers and the range 
of service providers indicated above. An Aboriginal Refer-
ence Group will guide and oversee the research to ensure 
the study is conducted according to principles of cultural 
security.21 It will provide advice regarding participant 
recruitment, relevant human and practical resources 
(eg, interpreters), community feedback from the trial 
and general cultural and ethical issues. The Reference 
Group will meet twice per year and provide other input 
as needed.
ETHICS AND DISSEMINATION
The protocol was approved by Royal Perth Hospital (the 
central ethics committee for the study #0000000125), St 
John of God Hospital (#1198), Edith Cowan University 
(#17291) and the WA Aboriginal Health (#794) Human 
Research Ethics Committees. The principal investigator, 
or her delegate, will be responsible for reporting any 
SAEs to the Ethics Committees as soon as possible, and in 
accordance with the guidelines of the Ethics Committee. 
Any protocol modifications will be approved by all ethics 
committees and conveyed to all partner investigators at 
each site.
This study will be carried out according to the Decla-
ration of Helsinki, the NHMRC National Statement on 
Ethical Conduct in Research Involving Humans (2007; 
updated 2018)55 and the Notes for Guidance on Good 
Clinical Practice (GCP) as adopted by the Australian 
Therapeutic Goods Administration (2000) (CPMP/
ICH/135/95), the ICH GCP guidelines.56 Conducting 
research with and within Aboriginal communities 
carries significant responsibilities central to the research 
8 Armstrong E, et al. BMJ Open 2021;11:e045898. doi:10.1136/bmjopen-2020-045898
Open access 
practices of the study. An Aboriginal research frame-
work25 incorporating principles of cultural security21 will 
be used in this study, which will align with the National 
Health & Medical Research Council ‘Ethical conduct 
for research with Aboriginal and Torres Strait Islander 
Peoples and communities: Guidelines for researchers 
and stakeholders 2018’,57 ‘Keeping Research on Track II 
2018’58 and the Australian Institute for Aboriginal and 
Torres Strait Islander Studies’ Guidelines for Ethical 
Research in Australian Indigenous Studies.59 All data will 
be de- identified and remain confidential throughout and 
subsequent to the trial completion.
Knowledge sharing and translation will be guided by 
a Knowledge Translation and Exchange Plan to guide 
key messaging and to identify audiences and enablers. 
Transfer of knowledge is planned through feedback 
sessions to all participants, to be given in multiple formats 
including workshops, community meetings, written 
reports and social media. More formal transfer will occur 
through input into national clinical guidelines, ongoing 
liaison with policymakers and dissemination of results 
through publications and conferences. Authorship of 
publications will include all research team investigators 
and project partners, with all publications approved by 
the Steering Committee.
DISCUSSION
This landmark study provides a novel, integrated complex 
intervention across a large geographical area in an under-
serviced population in real- life settings. The trial will 
provide vital information to shape much- needed service 
improvements for Aboriginal people following brain 
injury including economic information to support the 
planning and sustainability of future services.
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